Changing the Face of
One Patient at a Time
We Are Reveles
Latin word for discover.
We believe there are many essential therapies today that have not yet realized their full potential. Our dedicated team brings a rigorous approach to supporting the drug discovery and clinical development process. We aim to establish deep partnerships with sponsors, CROs, and research sites, and will work tirelessly to expand access and increase the awareness of clinical research.
With Reveles as your partner for Decentralized Clinical Trial solutions, you direct the course of your complex trial. Team up with our specialized expertise: We will help you assess needs and generate early insights that optimize your protocol — from translational research through commercialization.
Together, we can shape and advance your complex trial by leveraging Reveles' specialized pharmacist-driven model and network of highly-qualified home health care professionals.
Reveles' core team is comprised of industry-leading life science professionals with the shared principle that guides how we achieve our “why” – we have a team that is obsessed with people-centricity, driven by a relentless pursuit of operational excellence, and balanced by a culture of quality being a standard.
Meet Our Founder
I am deeply passionate about providing patient care and bringing hope closer to home for patients with rare diseases. Hope means so much more since sometimes that is all you have.
R'Kes Starling, RPh, MBA
President/Chief Executive Officer
As the founder and CEO, R'Kes is responsible for all aspects of strategic planning, corporate alliances, sales and marketing, operations, financial management, and regulatory compliance at Reveles Clinical Services. R'Kes has over17 years of leading high-touch pharmacy services, clinical operations, specialty drug distribution, and clinical research management to patients with rare and complex diseases such as Chronic Kidney disease, Cancer, Hemophilia, Cystic Fibrosis, and other complex diseases.
Prior to founding Reveles, R'Kes led McKesson's Specialty Pharmacy and Clinical Research Services businesses, which comprised of a large national, oncology-focused specialty pharmacy and the “central depot” that provides investigational product distribution, accountability, and storage for the US Oncology Research Network. He oversaw a multi-disciplinary clinical research team that has been involved in over 130 active oncology-focused clinical trials and was responsible for delivering over 50,000 annual shipments of investigational products, laboratory kits, and clinical supplies to the US Oncology network sites across the United States. Prior to McKesson, as the Vice President of Operations, he oversaw eight Home Infusion specialty pharmacies in six states with Coram CVS Specialty Infusion Services, which has translated into R'Kes having in-depth experience and knowledge of providing direct-to-patient care for thousands of patients on commercialized medications with complex and rare diseases in their homes.
R'Kes received his Executive Master’s in Business Administration from the Kellogg School Management, Northwestern University, and his bachelor’s degree from Purdue University in Pharmacy.